Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ventrus Poised For Run-Up Ahead Of Phase III Results
Seeking Alpha
Wednesday, July 17, 2013 - 11:01am
tags:
Ventrus, VEN 307
3 Potential Game Changers for COPD
Motley Fool
Wednesday, July 17, 2013 - 10:59am
tags:
COPD, Anoro, GSK, Theravance, QVA149, Novartis, olodaterol, Boehringer Ingelheim, Pfizer
Ariad Pharma skids as analyst says leukemia pill Iclusig may struggle against older drugs
Yahoo/AP
Wednesday, July 17, 2013 - 10:57am
tags:
Ariad Pharmaceuticals, Iclusig, chronic myeloid leukemia
Novartis raises '13 outlook despite 2Q profit drop
Yahoo/AP
Wednesday, July 17, 2013 - 10:55am
tags:
Novartis, earnings
Abbott’s Quarterly Profit Rises on Emerging Market Sales
Bloomberg
Wednesday, July 17, 2013 - 10:54am
tags:
Abbott Laboratories, earnings
Will GlaxoSmithKline Bribery Accusations Affect the Company’s Bottom Line?
Wall St. Cheat Sheet
Tuesday, July 16, 2013 - 12:36pm
tags:
GSK, bribery, China
Merck says FDA needs more time to complete sugammadex review
Reuters
Tuesday, July 16, 2013 - 12:35pm
tags:
FDA, Merck, sugammadex
First Manhattan sues Vivus for delaying shareholder meet
Reuters
Tuesday, July 16, 2013 - 11:24am
tags:
Vivus
Alexion Takeover Would Be Priciest Since 2008: Real M&A
Bloomberg
Tuesday, July 16, 2013 - 11:21am
tags:
Alexion, Roche, M&A
Largest cancer gene database made public
Reuters
Tuesday, July 16, 2013 - 11:20am
tags:
cancer, Roche, gene database, Cisplatin, Zelboraf, Pfizer, Xalkori
Merck maintains lead in BACE inhibitors for Alzheimer's
PM Live
Tuesday, July 16, 2013 - 10:47am
tags:
Merck, Alzheimer's disease, BACE inhibitors, MK-8931
Is Big Pharma Crazy for Chasing This Deal?
Motley Fool
Tuesday, July 16, 2013 - 10:27am
tags:
Alexion, Roche, M&A
Actavis launching generic version of GlaxoSmithKline's Lamictal for epilepsy, bipolar disorder
Yahoo/AP
Tuesday, July 16, 2013 - 9:26am
tags:
GSK, Actavis, Lamictal, generics, epilepsy
5 more countries OK Pfizer's Xeljanz
Yahoo/AP
Tuesday, July 16, 2013 - 9:25am
tags:
Pfizer, rheumatoid arthritis, Xeljanz
Abbott Labs Earnings Have a Lot of Catching Up to Do
Motley Fool
Tuesday, July 16, 2013 - 9:24am
tags:
earnings, Abbott Laboratories
Police Say Sexual Favors Spur $1.5 Billion Glaxo China Sales
Bloomberg
Tuesday, July 16, 2013 - 9:23am
tags:
China, GSK
J&J results beat expectations, as drugs, devices deliver
Reuters
Tuesday, July 16, 2013 - 9:22am
tags:
earnings, JNJ
Tranzyme announces completion of merger with Ocera Therapeutics
Yahoo/Fly on the Wall
Monday, July 15, 2013 - 2:23pm
tags:
Tranzyme, Ocera Therapeutics, M&A
Peregrine's 4Q Loss In Line
Yahoo/Zacks
Monday, July 15, 2013 - 1:40pm
tags:
earnings, Peregrine Pharmaceuticals
Novartis (NVS) Profit Expected to Slip
Forbes
Monday, July 15, 2013 - 1:31pm
tags:
Novartis, earnins

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.